PharmaLex Denmark A/S: Financial statements 2018
CVR: 18652439
Source: annual report 2018, Danish Business Authority
01/01/2018 – 31/12/2018
PharmaLex Denmark A/S (CVR 18652439) has filed annual accounts for 2018. In 2018, the company reported a gross profit of DKK 13,391,778 and a net result of DKK 2,874,449 compared with DKK -1,627,342 the year before. That is a decrease of 7.9% compared with the year before. Equity in the 2018 report amounted to DKK 4,122,518. The solvency ratio was 58.3%. The company had 15 employees in the financial year.
- Gross Profit
- DKK 13,391,778
- Profit/Loss
- DKK 2,874,449
- Equity
- DKK 4,122,518
- Total Assets
- DKK 7,066,714
- Employees
- 15
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2018 | - | 13.4 mio. | 2.9 mio. | 4.1 mio. | 15 |
| 2017 | - | 14.5 mio. | -1.6 mio. | 1.2 mio. | 21 |
| 2016 | - | 22.4 mio. | 5.3 mio. | 6.6 mio. | 30 |
| 2015 | - | 17.6 mio. | 321 t. | 4.9 mio. | - |
| 2014 | - | 15.4 mio. | 2.2 mio. | 6.8 mio. | - |
Official annual report
Fetch this data via API
Every Danish company, financial statement and ownership record — straight into your own systems or your AI assistant via MCP.
See the API documentationEvents in 2018
PharmaLex Denmark A/S has published its annual report for 2017. Gross profit came to DKK 14,539,514, and the net result was DKK -1,627,342.
As of March 20, 2018, Eva Edil has joined the board of directors of PharmaLex Denmark A/S.
As of March 20, 2018, Dr. Thomas Stefan Dobmeyer has joined the board of directors of PharmaLex Denmark A/S.
As of March 20, 2018, Anette Langgaard Jacobsen has left the board of directors of PharmaLex Denmark A/S.
As of March 19, 2018, Dr. Thomas Stefan Dobmeyer has left the board of directors of PharmaLex Denmark A/S.
As of January 17, 2018, Dr. Thomas Stefan Dobmeyer has joined the board of directors of PharmaLex Denmark A/S.
As of January 17, 2018, Solveig Blomvik has left the board of directors of PharmaLex Denmark A/S.
About PharmaLex Denmark A/S
PharmaLex Denmark A/S is a Danish company of the type Aktieselskab based in Kongens Lyngby, founded in 1995. The company is registered under the industry Virksomhedsrådgivning og anden ledelsesrådgivning. The company was previously named JACOBSEN PHARMA CONSULTANCY A/S and SLP NR. 11.026 A/S. The management consists of Åsa Pihlblad. The board consists of Christopher Gauglitz (chair), Carlos Antonio Santaflorentina Juanino and Åsa Pihlblad. The company is owned by Pharmalex Nordic ApS. The company has 15 employees (2026). In 2025, the company reported a gross profit of DKK 17,235,093 and a net result of DKK -1,712,095 compared with DKK 1,745,746 the year before. Equity in the 2025 report amounted to DKK 2,761,242.